{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:59:20Z","timestamp":1765382360513,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.iac.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T08:17:47Z","timestamp":1656577067000},"page":"691-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap"],"prefix":"10.1016","volume":"42","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2022.04.006_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jaip.2019.10.044","article-title":"Asthma-COPD overlap and chronic airflow obstruction: definitions, management, and unanswered questions","volume":"8","author":"Milne","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2022.04.006_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2016.04.028","article-title":"Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?","volume":"138","author":"Cazzola","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.04.006_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccm.2020.06.006","article-title":"What is asthma chronic obstructive pulmonary disease overlap?","volume":"41","author":"Halpin","year":"2020","journal-title":"Clin Chest Med"},{"author":"Global Inititative for Asthma","key":"10.1016\/j.iac.2022.04.006_bib5"},{"issue":"1","key":"10.1016\/j.iac.2022.04.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCP.0000000000000547","article-title":"The many faces of asthma-chronic obstructive pulmonary disease overlap","volume":"25","author":"Boulet","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"159","key":"10.1016\/j.iac.2022.04.006_bib7","doi-asserted-by":"crossref","first-page":"190185","DOI":"10.1183\/16000617.0185-2019","article-title":"Asthma-COPD overlap: current understanding and the utility of experimental models","volume":"30","author":"Tu","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.iac.2022.04.006_bib8","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/COPD.S312560","article-title":"Update on asthma-COPD overlap (ACO): a narrative review","volume":"16","author":"Mekov","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.iac.2022.04.006_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s13665-021-00284-0","article-title":"Asthma-COPD overlap","author":"Sam","year":"2022","journal-title":"Curr Pulmonol Rep"},{"key":"10.1016\/j.iac.2022.04.006_bib10","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2147\/COPD.S54927","article-title":"Airflow obstruction: is it asthma or is it COPD?","volume":"11","author":"Rogliani","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.iac.2022.04.006_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.alit.2018.01.002","article-title":"Definition and diagnosis of asthma-COPD overlap (ACO)","volume":"67","author":"Yanagisawa","year":"2018","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.iac.2022.04.006_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2021.09.036","article-title":"Asthma-COPD overlap: what are the important questions?","volume":"161","author":"Leung","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.iac.2022.04.006_bib13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/COPD.S113647","article-title":"Inflammatory biomarkers in asthma-COPD overlap syndrome","volume":"11","author":"Kobayashi","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.iac.2022.04.006_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40291-019-00413-1","article-title":"Evolving concepts in chronic obstructive pulmonary disease blood-based biomarkers","volume":"23","author":"Cazzola","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"10.1016\/j.iac.2022.04.006_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40291-021-00514-w","article-title":"Treatable mechanisms in asthma","volume":"25","author":"Cazzola","year":"2021","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10.1016\/j.iac.2022.04.006_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13223-021-00548-z","article-title":"Characteristics of inflammatory phenotypes among patients with asthma: relationships of blood count parameters with sputum cellular phenotypes","volume":"17","author":"Shi","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.iac.2022.04.006_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/COPD.S153694","article-title":"Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach","volume":"13","author":"de Llano","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.iac.2022.04.006_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaip.2018.06.015","article-title":"Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap","volume":"7","author":"Shirai","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2022.04.006_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaip.2018.07.002","article-title":"Can we define asthma-COPD overlap (ACO) by biomarkers?","volume":"7","author":"Izuhara","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2022.04.006_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2019.03.006","article-title":"Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain","volume":"151","author":"P\u00e9rez de Llano","year":"2019","journal-title":"ENEAS Study Respir Med"},{"issue":"3","key":"10.1016\/j.iac.2022.04.006_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1152\/physrev.00023.2019","article-title":"Are we meeting the promise of endotypes and precision medicine in asthma?","volume":"100","author":"Ray","year":"2020","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.iac.2022.04.006_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00281-019-00776-x","article-title":"Omics for the future in asthma","volume":"42","author":"Abdel-Aziz","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.iac.2022.04.006_bib23","doi-asserted-by":"crossref","first-page":"2003927","DOI":"10.1183\/13993003.03927-2020","article-title":"Heterogeneity within and between physician-diagnosed asthma and\/or COPD: NOVELTY cohort","volume":"58","author":"Reddel","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.iac.2022.04.006_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/02770903.2017.1339799","article-title":"Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample","volume":"55","author":"Ekerljung","year":"2018","journal-title":"J Asthma"},{"issue":"3","key":"10.1016\/j.iac.2022.04.006_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.anai.2016.12.016","article-title":"Asthma-chronic obstructive pulmonary disease overlap syndrome: What we know and what we need to find out","volume":"118","author":"Desai","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2022.04.006_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000455395","article-title":"Personalised medicine for asthma and chronic obstructive pulmonary disease","volume":"93","author":"Heaney","year":"2017","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.iac.2022.04.006_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.anai.2019.07.021","article-title":"Management of asthma COPD overlap","volume":"123","author":"Maselli","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"year":"2018","series-title":"The JRS guidelines for the management of ACO 2018. (In Japanese)","key":"10.1016\/j.iac.2022.04.006_bib28"},{"issue":"Suppl. 1","key":"10.1016\/j.iac.2022.04.006_bib29","first-page":"2","article-title":"[Guidelines for asthma management. (In Spanish)]","volume":"51","year":"2015","journal-title":"Arch Bronconeumol"},{"issue":"4","key":"10.1016\/j.iac.2022.04.006_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.23822\/EurAnnACI.1764-1489.138","article-title":"Asthma and COPD \"overlap\": a treatable trait or common several treatable-traits?","volume":"52","author":"Gaspar Marques","year":"2020","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2022.04.006_bib31","doi-asserted-by":"crossref","first-page":"101021","DOI":"10.1016\/j.mam.2021.101021","article-title":"Asthma COPD overlap: Insights into cellular and molecular mechanisms","volume":"85","author":"Morissette","year":"2022","journal-title":"Mol Aspects Med"},{"issue":"11","key":"10.1016\/j.iac.2022.04.006_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"17","key":"10.1016\/j.iac.2022.04.006_bib33","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2022.04.006_bib34","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2018.11.032","article-title":"Omalizumab effectiveness in asthma-COPD overlap: post hoc analysis of PROSPERO","volume":"143","author":"Hanania","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2022.04.006_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2019.11.008","article-title":"Allergic endotypes and phenotypes of asthma","volume":"8","author":"Akar-Ghibril","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2022.04.006_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13665-020-00244-0","article-title":"Eosinophilic vs. neutrophilic asthma","volume":"9","author":"Assaf","year":"2020","journal-title":"Curr Pulmonol Rep"},{"key":"10.1016\/j.iac.2022.04.006_bib37","first-page":"363","article-title":"An overview of the safety and efficacy of monoclonal antibodies for the chronic obstructive pulmonary disease","volume":"15","author":"Cazzola","year":"2021","journal-title":"Biologics"},{"issue":"9","key":"10.1016\/j.iac.2022.04.006_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-2600(15)00254-4","article-title":"The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?","volume":"3","author":"Bateman","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:18Z","timestamp":1760179518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856122000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0889856122000285"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2022.04.006","relation":{},"ISSN":["0889-8561"],"issn-type":[{"type":"print","value":"0889-8561"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}